- Home
- NRT vs ECOR Comparison
NRT vs ECOR Comparison
Compare NRT & ECOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRT
- ECOR
- Stock Information
- Founded
- NRT 1975
- ECOR 2005
- Country
- NRT United States
- ECOR United States
- Employees
- NRT N/A
- ECOR N/A
- Industry
- NRT Oil & Gas Production
- ECOR Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NRT Energy
- ECOR Health Care
- Exchange
- NRT Nasdaq
- ECOR Nasdaq
- Market Cap
- NRT 46.4M
- ECOR 39.7M
- IPO Year
- NRT N/A
- ECOR 2018
- Fundamental
- Price
- NRT $5.09
- ECOR $7.75
- Analyst Decision
- NRT
- ECOR Strong Buy
- Analyst Count
- NRT 0
- ECOR 2
- Target Price
- NRT N/A
- ECOR $25.50
- AVG Volume (30 Days)
- NRT 19.8K
- ECOR 118.8K
- Earning Date
- NRT 08-29-2025
- ECOR 08-06-2025
- Dividend Yield
- NRT 9.49%
- ECOR N/A
- EPS Growth
- NRT 24.05
- ECOR N/A
- EPS
- NRT 0.59
- ECOR N/A
- Revenue
- NRT $6,184,173.00
- ECOR $26,458,000.00
- Revenue This Year
- NRT N/A
- ECOR $23.21
- Revenue Next Year
- NRT N/A
- ECOR $44.10
- P/E Ratio
- NRT $8.76
- ECOR N/A
- Revenue Growth
- NRT 18.55
- ECOR 41.54
- 52 Week Low
- NRT $3.88
- ECOR $4.47
- 52 Week High
- NRT $6.75
- ECOR $19.49
- Technical
- Relative Strength Index (RSI)
- NRT 54.10
- ECOR 64.43
- Support Level
- NRT $4.65
- ECOR $6.57
- Resistance Level
- NRT $5.03
- ECOR $7.80
- Average True Range (ATR)
- NRT 0.19
- ECOR 0.74
- MACD
- NRT 0.02
- ECOR 0.03
- Stochastic Oscillator
- NRT 69.21
- ECOR 63.97
About NRT North European Oil Royality Trust
North European Oil Royalty Trust holds overriding royalty rights covering gas and oil production in certain concessions or leases in the Federal Republic of Germany. The properties of the trust are overriding royalty rights on sales of gas, sulfur, and oil under certain concessions or leases in the Federal Republic of Germany. The trust also holds other royalty rights, which are based on leases. It receives various percentages of royalties on the proceeds of the sales of certain products from the areas involved.
About ECOR electroCore Inc.
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.